Latest Period
Q4 2025
- Info
- Insider Trading
- Financials
- Holders
Security Snapshot
Passage BIO, Inc. - COM NEW (PASG) Institutional Ownership
CUSIP: 702712209
13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025
Institutions Reporting
28
Shares (Excl. Options)
1,577,408
Price
$11.80
- Type / Class
- Equity / COM NEW
- Symbol
- PASG on Nasdaq
- Price per share
- $8.79
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 1,577,408
- Total reported value
- $18,609,960
- % of total 13F portfolios
- 0%
- Share change
- +5,922
- Value change
- +$657,198
- Number of holders
- 28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- PASG - Passage BIO, Inc. - COM NEW is tracked under CUSIP 702712209.
- 28 institutions reported positions in Q4 2025.
- Schedule 13D/13G significant owner rows are not currently available.
What Changed
- Holder count moved from 29 to 28 between Q3 2025 and Q4 2025.
- Reported value moved from $12,546,742 to $18,609,960.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Official SEC Source
Backed by Form 13F
Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.
See Original FilingInvestment Quick Answers
What is CUSIP 702712209?
CUSIP 702712209 identifies PASG - Passage BIO, Inc. - COM NEW in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Continue Investment Research
- Latest 13F filings for new institutional portfolio disclosures.
- Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
- Latest 10-Q/10-K reports to cross-check issuer fundamentals.
- Recent insider transactions for management buying/selling context.
- SEC investors directory and top value investors for manager-level discovery.
- All institutional ownership pages to compare adjacent CUSIP pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 702712209:
As of 31 Dec 2025, 28 institutional investors reported holding 1,577,408 shares of Passage BIO, Inc. - COM NEW (PASG).